{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:24:15Z","timestamp":1787066655759,"version":"build-2736575974"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,6,11]],"date-time":"2015-06-11T00:00:00Z","timestamp":1433980800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,6,11]],"date-time":"2015-06-11T00:00:00Z","timestamp":1433980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Gastro"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s11938-015-0059-6","type":"journal-article","created":{"date-parts":[[2015,6,11]],"date-time":"2015-06-11T00:11:18Z","timestamp":1433981478000},"page":"275-286","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Challenges in the Diagnosis and Management of Inflammatory Bowel Disease in the Elderly"],"prefix":"10.1007","volume":"13","author":[{"given":"Sasha","family":"Taleban","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,6,11]]},"reference":[{"key":"59_CR1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1056\/NEJM195307162490302","volume":"249","author":"BM Banks","year":"1953","unstructured":"Banks BM, Klayman MI. Idiopathic ulcerative colitis beginning after the age of fifty. N Engl J Med. 1953;249:91\u20136.","journal-title":"N Engl J Med"},{"key":"59_CR2","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S0016-5085(19)35090-5","volume":"41","author":"DH Law","year":"1961","unstructured":"Law DH, Steinberg H, Sleisenger MH. Ulcerative colitis with onset after the age fifty. Gastroenterology. 1961;41:457\u201364.","journal-title":"Gastroenterology"},{"key":"59_CR3","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/S0016-5085(19)35528-3","volume":"35","author":"FW Nugent","year":"1958","unstructured":"Nugent FW. Regional ileitis with onset in patients over fifty years of age. Gastroenterology. 1958;35:418\u20139.","journal-title":"Gastroenterology"},{"key":"59_CR4","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.3748\/wjg.v17.i22.2734","volume":"17","author":"JH del Val","year":"2011","unstructured":"del Val JH. Old-age inflammatory bowel disease onset: a different problem? World J Gastroenterol. 2011;17:2734\u20139.","journal-title":"World J Gastroenterol"},{"key":"59_CR5","doi-asserted-by":"publisher","first-page":"617","DOI":"10.2165\/11537340-000000000-00000","volume":"27","author":"SW Hussain","year":"2010","unstructured":"Hussain SW, Pardi DS. Inflammatory bowel disease in the elderly. Drugs Aging. 2010;27:617\u201324.","journal-title":"Drugs Aging"},{"key":"59_CR6","first-page":"337","volume":"4","author":"S Katz","year":"2008","unstructured":"Katz S, Feldstein R. Inflammatory bowel disease of the elderly: a wake-up call. Gastroenterol Hepatol. 2008;4:337\u201347.","journal-title":"Gastroenterol Hepatol"},{"key":"59_CR7","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1038\/ajg.2011.271","volume":"106","author":"S Katz","year":"2011","unstructured":"Katz S, Pardi DS. Inflammatory bowel disease of the elderly: frequently asked questions (FAQs). Am J Gastroenterol. 2011;106:1889\u201397.","journal-title":"Am J Gastroenterol"},{"key":"59_CR8","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrgastro.2013.240","volume":"11","author":"J Ruel","year":"2014","unstructured":"Ruel J, Ruane D, Mehandru S, et al. IBD across the age spectrum: is it the same disease? Nat Rev Gastroenterol Hepatol. 2014;11:88\u201398.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"59_CR9","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1136\/gutjnl-2012-303864","volume":"63","author":"C Charpentier","year":"2014","unstructured":"Charpentier C, Salleron J, Savoye G, et al. Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study. Gut. 2014;63:423\u201332. Population-based French study using EPIMAD registry between 1988\u20132006 that leads to many of the conclusions about the natural history and approach to treatment in older-onset IBD.","journal-title":"Gut"},{"key":"59_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.crohns.2010.08.004","volume":"5","author":"PL Lakatos","year":"2011","unstructured":"Lakatos PL, David G, Pandur T, et al. IBD in the elderly population: results from a population-based study in Western Hungary, 1977\u20132008. J Crohns Colitis. 2011;5:5\u201313. Population-based Hungarian study between 1977\u20132008 that leads to many of the conclusions about the natural history and approach to treatment in older-onset IBD.","journal-title":"J Crohns Colitis"},{"key":"59_CR11","unstructured":"In: A profile of older Americans. 2011. Administration of aging. http:\/\/aoa.gov\/Aging_Statistics\/Profile\/2011\/4.aspx. Accessed 25 Jan 2015."},{"key":"59_CR12","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1053\/j.gastro.2011.10.001","volume":"142","author":"NA Molodecky","year":"2012","unstructured":"Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46\u201354.","journal-title":"Gastroenterology"},{"key":"59_CR13","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.clinbiochem.2014.01.003","volume":"47","author":"T Nilsen","year":"2014","unstructured":"Nilsen T, Sundstr\u00f6m J, Lind L, et al. Serum calprotectin levels in elderly males and females without bacterial or viral infections. Clin Biochem. 2014;47:1065\u20138.","journal-title":"Clin Biochem"},{"key":"59_CR14","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1177\/0733464803022002004","volume":"22","author":"MA Stoller","year":"2003","unstructured":"Stoller MA, Stoller EP. Perceived income adequacy among elderly retirees. J Appl Gerontol. 2003;22:230\u201351.","journal-title":"J Appl Gerontol"},{"key":"59_CR15","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/S1091-255X(01)00060-9","volume":"6","author":"MJ Page","year":"2002","unstructured":"Page MJ, Poritz LS, Kunselman SJ, et al. Factors affecting surgical risk in elderly patients with inflammatory bowel disease. J Gastrointest Surg. 2002;6:606\u201313.","journal-title":"J Gastrointest Surg"},{"key":"59_CR16","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.jamcollsurg.2014.01.053","volume":"218","author":"CE Collins","year":"2014","unstructured":"Collins CE, Ayturk MD, Flahive JM, et al. Epidemiology and outcomes of community-acquired clostridium difficile infections in medicare beneficiaries. J Am Coll Surg. 2014;218:1141\u20137.","journal-title":"J Am Coll Surg"},{"key":"59_CR17","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s00228-014-1734-6","volume":"70","author":"M Wehling","year":"2014","unstructured":"Wehling M. Non-steroidal anti-inflammatory drug use in chronic pain conditions with special emphasis on the elderly and patients with relevant comorbidities: management and mitigation of risks and adverse effects. Eur J Clin Pharmacol. 2014;70:1159\u201372.","journal-title":"Eur J Clin Pharmacol"},{"key":"59_CR18","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1053\/j.gastro.2013.04.007","volume":"145","author":"SC Ng","year":"2013","unstructured":"Ng SC, Tang W, Ching JY, et al. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn\u2019s and colitis epidemiology study. Gastroenterology. 2013;145:158\u201365.","journal-title":"Gastroenterology"},{"key":"59_CR19","doi-asserted-by":"publisher","first-page":"S-406","DOI":"10.1016\/S0016-5085(13)61497-3","volume":"144","author":"AM Parian","year":"2013","unstructured":"Parian AM, Ha CY. Su1130 severe polypharmacy and major medication interactions are associated with increasing age and comorbidity among inflammatory bowel disease patients. Gastroenterology. 2013;144:S-406.","journal-title":"Gastroenterology"},{"key":"59_CR20","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/nrgastro.2014.202","volume":"12","author":"S Singh","year":"2015","unstructured":"Singh S, Kullo IJ, Pardi DS, et al. Epidemiology, risk factors and management of cardiovascular diseases in IBD. Nat Rev Gastroenterol Hepatol. 2015;12:26\u201335.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"59_CR21","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.crohns.2013.07.002","volume":"8","author":"MD Long","year":"2014","unstructured":"Long MD, Kappelman MD, Martin CF, et al. Risk factors for depression in the elderly inflammatory bowel disease population. J Crohns Colitis. 2014;8:113\u20139.","journal-title":"J Crohns Colitis"},{"key":"59_CR22","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1016\/S0140-6736(97)01007-6","volume":"349","author":"JE Graham","year":"1997","unstructured":"Graham JE, Rockwood K, Beattie BL, et al. Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet. 1997;349:1793\u20136.","journal-title":"Lancet"},{"key":"59_CR23","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1080\/08923970601067326","volume":"28","author":"L Amati","year":"2006","unstructured":"Amati L, Passeri M, Selicato F, et al. New insights into the biological and clinical significance of fecal calprotectin in inflammatory bowel disease. Immunopharmacol Immunotoxicol. 2006;28:665\u201381.","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"59_CR24","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1258\/acb.2009.009061","volume":"47","author":"S Joshi","year":"2010","unstructured":"Joshi S, Lewis SJ, Creanor S, et al. Age-related faecal calprotectin, lactoferrin and tumour M2-PK concentrations in healthy volunteers. Ann Clin Biochem. 2010;47:259\u201363.","journal-title":"Ann Clin Biochem"},{"key":"59_CR25","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s11938-003-0003-z","volume":"6","author":"DA Greenwald","year":"2003","unstructured":"Greenwald DA, Brandt LJ. Inflammatory bowel disease after age 60. Curr Treat Options Gastroenterol. 2003;6:213\u201325.","journal-title":"Curr Treat Options Gastroenterol"},{"key":"59_CR26","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.cgh.2010.09.026","volume":"9","author":"M Cottone","year":"2011","unstructured":"Cottone M, Kohn A, Daperno M, et al. Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease. Clin Gastroenterol Hepatol. 2011;9:30\u20135. Multicenter retrospective Italian study from 2000\u20132009 evaluating the safety of infliximab and adalimumab in patients >65 years old is responsible for several of the conclusions drawn regarding efficacy and safety profile of biologic use in elderly.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"59_CR27","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.cgh.2010.01.001","volume":"8","author":"S Vermeire","year":"2010","unstructured":"Vermeire S, Schreiber S, Sandborn WJ, et al. Correlation between the Crohn\u2019s disease activity and Harvey-Bradshaw indices in assessing Crohn\u2019s disease severity. Clin Gastroenterol Hepatol. 2010;8:357\u201363.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"59_CR28","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1136\/gut.40.6.775","volume":"40","author":"JK Marshall","year":"1997","unstructured":"Marshall JK, Irvine EJ. Rectal corticosteroids versus alternative treatments in ulcerative colitis: a meta-analysis. Gut. 1997;40:775\u201381.","journal-title":"Gut"},{"key":"59_CR29","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1136\/gut.2004.060103","volume":"54","author":"P Marteau","year":"2005","unstructured":"Marteau P, Probert CS, Lindgren S, et al. Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild\/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study. Gut. 2005;54:960\u20135.","journal-title":"Gut"},{"key":"59_CR30","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1111\/j.1572-0241.2001.04683.x","volume":"96","author":"SV Kane","year":"2001","unstructured":"Kane SV, Cohen RD, Aikens JE, et al. Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis. Am J Gastroenterol. 2001;96:2929\u201333.","journal-title":"Am J Gastroenterol"},{"key":"59_CR31","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1002\/ibd.21938","volume":"18","author":"AB Hawthorne","year":"2012","unstructured":"Hawthorne AB, Stenson R, Gillespie D, et al. One-year investigator-blind randomized multicenter trial comparing Asacol 2.4 g once daily with 800 mg three times daily for maintenance of remission in ulcerative colitis. Inflamm Bowel Dis. 2012;18:1885\u201393.","journal-title":"Inflamm Bowel Dis"},{"key":"59_CR32","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.1007\/s10620-011-1877-6","volume":"56","author":"SV Kane","year":"2011","unstructured":"Kane SV, Sumner M, Solomon D, et al. Twelve-month persistency with oral 5-aminosalicylic acid therapy for ulcerative colitis: results from a large pharmacy prescriptions database. Dig Dis Sci. 2011;56:3463\u201370.","journal-title":"Dig Dis Sci"},{"key":"59_CR33","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/ajg.2011.71","volume":"106","author":"AC Ford","year":"2011","unstructured":"Ford AC, Kane SV, Khan KJ, et al. Efficacy of 5-aminosalicylates in Crohn\u2019s disease: systematic review and meta-analysis. Am J Gastroenterol. 2011;106:617\u201329.","journal-title":"Am J Gastroenterol"},{"key":"59_CR34","doi-asserted-by":"crossref","unstructured":"Lim WC, Hanauer S. Aminosalicylates for induction of remission or response in Crohn\u2019s disease. Cochrane Database Syst Rev 2010:Cd008870.","DOI":"10.1002\/14651858.CD008870"},{"key":"59_CR35","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/ajg.2008.168","volume":"104","author":"GR Lichtenstein","year":"2009","unstructured":"Lichtenstein GR, Hanauer SB, Sandborn WJ. Management of Crohn\u2019s disease in adults. Am J Gastroenterol. 2009;104:465\u201383. The American College of Gastroenterology guidelines for the management of adult CD.","journal-title":"Am J Gastroenterol"},{"key":"59_CR36","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1053\/j.gastro.2012.08.003","volume":"143","author":"WJ Sandborn","year":"2012","unstructured":"Sandborn WJ, Travis S, Moro L, et al. Once-daily budesonide MMX\u00ae extended-release tablets induce remission in patients with mild to moderate ulcerative colitis: results from the CORE I study. Gastroenterology. 2012;143:1218\u201326.","journal-title":"Gastroenterology"},{"key":"59_CR37","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/ajg.2011.72","volume":"106","author":"KJ Khan","year":"2011","unstructured":"Khan KJ, Ullman TA, Ford AC, et al. Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis. Am J Gastroenterol. 2011;106:661\u201373.","journal-title":"Am J Gastroenterol"},{"key":"59_CR38","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1053\/j.gastro.2004.03.016","volume":"126","author":"TP Van Staa","year":"2004","unstructured":"Van Staa TP, Travis S, Leufkens HG, et al. 5-Aminosalicylic acids and the risk of renal disease: a large British epidemiologic study. Gastroenterology. 2004;126:1733\u20139.","journal-title":"Gastroenterology"},{"key":"59_CR39","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/ibd.20099","volume":"13","author":"JP Gisbert","year":"2007","unstructured":"Gisbert JP, Gonzalez-Lama Y, Mate J. 5-Aminosalicylates and renal function in inflammatory bowel disease: a systematic review. Inflamm Bowel Dis. 2007;13:629\u201338.","journal-title":"Inflamm Bowel Dis"},{"key":"59_CR40","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1111\/j.1476-5381.2010.00731.x","volume":"160","author":"P de Graaf","year":"2010","unstructured":"de Graaf P, de Boer NK, Wong DR, et al. Influence of 5-aminosalicylic acid on 6-thioguanosine phosphate metabolite levels: a prospective study in patients under steady thiopurine therapy. Br J Pharmacol. 2010;160:1083\u201391.","journal-title":"Br J Pharmacol"},{"key":"59_CR41","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1111\/j.1572-0241.2002.05609.x","volume":"97","author":"M Cino","year":"2002","unstructured":"Cino M, Greenberg GR. Bone mineral density in Crohn\u2019s disease: a longitudinal study of budesonide, prednisone, and nonsteroid therapy. Am J Gastroenterol. 2002;97:915\u201321.","journal-title":"Am J Gastroenterol"},{"key":"59_CR42","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1056\/NEJM199409293311304","volume":"331","author":"P Rutgeerts","year":"1994","unstructured":"Rutgeerts P, Lofberg R, Malchow H, et al. A comparison of budesonide with prednisolone for active Crohn\u2019s disease. N Engl J Med. 1994;331:842\u20135.","journal-title":"N Engl J Med"},{"key":"59_CR43","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/ibd.20628","volume":"15","author":"AN Ananthakrishnan","year":"2009","unstructured":"Ananthakrishnan AN, McGinley EL, Binion DG. Inflammatory bowel disease in the elderly is associated with worse outcomes: a national study of hospitalizations. Inflamm Bowel Dis. 2009;15:182\u20139.","journal-title":"Inflamm Bowel Dis"},{"key":"59_CR44","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/ajg.2009.727","volume":"105","author":"A Kornbluth","year":"2010","unstructured":"Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults: American college of gastroenterology, practice parameters committee. Am J Gastroenterol. 2010;105:501\u201323. The American College of Gastroenterology guidelines for the management of adult UC.","journal-title":"Am J Gastroenterol"},{"key":"59_CR45","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/ibd.23026","volume":"19","author":"A Desai","year":"2013","unstructured":"Desai A, Zator ZA, de Silva P, et al. Older age is associated with higher rate of discontinuation of anti-TNF therapy in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2013;19:309\u201315. Along with [26], this retrospective single-center study evaluated the efficacy of ant-TNF agents in the elderly.","journal-title":"Inflamm Bowel Dis"},{"key":"59_CR46","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1056\/NEJMoa1215734","volume":"369","author":"BG Feagan","year":"2013","unstructured":"Feagan BG, Rutgeerts P, Sands BE, et al. Vedolizumab as induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2013;369:699\u2013710.","journal-title":"N Engl J Med"},{"key":"59_CR47","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1215739","volume":"369","author":"WJ Sandborn","year":"2013","unstructured":"Sandborn WJ, Feagan BG, Rutgeerts P, et al. Vedolizumab as induction and maintenance therapy for Crohn\u2019s disease. N Engl J Med. 2013;369:711\u201321.","journal-title":"N Engl J Med"},{"key":"59_CR48","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1007\/s10620-012-2083-x","volume":"57","author":"M Juneja","year":"2012","unstructured":"Juneja M, Baidoo L, Schwartz MB, et al. Geriatric inflammatory bowel disease: phenotypic presentation, treatment patterns, nutritional status, outcomes, and comorbidity. Dig Dis Sci. 2012;57:2408\u201315.","journal-title":"Dig Dis Sci"},{"key":"59_CR49","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1053\/j.gastro.2008.01.012","volume":"134","author":"M Toruner","year":"2008","unstructured":"Toruner M, Loftus Jr EV, Harmsen WS, et al. Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology. 2008;134:929\u201336.","journal-title":"Gastroenterology"},{"key":"59_CR50","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1038\/ajg.2014.313","volume":"109","author":"P Brassard","year":"2014","unstructured":"Brassard P, Bitton A, Suissa A, et al. Oral corticosteroids and the risk of serious infections in patients with elderly-onset inflammatory bowel diseases. Am J Gastroenterol. 2014;109:1795\u2013802.","journal-title":"Am J Gastroenterol"},{"key":"59_CR51","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1038\/ajg.2012.218","volume":"107","author":"GR Lichtenstein","year":"2012","unstructured":"Lichtenstein GR, Feagan BG, Cohen RD, et al. Serious infection and mortality in patients with Crohn\u2019s disease: more than 5 years of follow-up in the TREAT registry. Am J Gastroenterol. 2012;107:1409\u201322. Large, prospective, observational registry comparing risk factors for serious infection and mortality among CD patients taking or not taking infliximab.","journal-title":"Am J Gastroenterol"},{"key":"59_CR52","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1136\/gutjnl-2013-305763","volume":"63","author":"L Beaugerie","year":"2013","unstructured":"Beaugerie L, Carrat F, Colombel JF, et al. Risk of new or recurrent cancer under immunosuppressive therapy in patients with IBD and previous cancer. Gut. 2013;63:1416\u201323.","journal-title":"Gut"},{"key":"59_CR53","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1053\/j.gastro.2013.07.035","volume":"145","author":"N Khan","year":"2013","unstructured":"Khan N, Abbas AM, Lichtenstein GR, et al. Risk of lymphoma in patients with ulcerative colitis treated with thiopurines: a nationwide retrospective cohort study. Gastroenterology. 2013;145:1007\u201315.","journal-title":"Gastroenterology"},{"key":"59_CR54","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/ajg.2013.441","volume":"109","author":"GR Lichtenstein","year":"2014","unstructured":"Lichtenstein GR, Feagan BG, Cohen RD, et al. Drug therapies and the risk of malignancy in Crohn\u2019s disease: results from the TREAT Registry. Am J Gastroenterol. 2014;109:212\u201323. Large, prospective, observational registry comparing risk factors for various malignancies among CD patients taking or not taking infliximab.","journal-title":"Am J Gastroenterol"},{"key":"59_CR55","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.1182\/blood.V99.11.3909","volume":"99","author":"X Mariette","year":"2002","unstructured":"Mariette X, Cazals-Hatem D, Warszawki J, et al. Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France. Blood. 2002;99:3909\u201315.","journal-title":"Blood"},{"key":"59_CR56","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1002\/art.20311","volume":"50","author":"F Wolfe","year":"2004","unstructured":"Wolfe F, Michaud K. Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients. Arthritis Rheum. 2004;50:1740\u201351.","journal-title":"Arthritis Rheum"},{"key":"59_CR57","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.cgh.2009.01.004","volume":"7","author":"CA Siegel","year":"2009","unstructured":"Siegel CA, Marden SM, Persing SM, et al. Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy for the treatment of Crohn\u2019s disease: a meta-analysis. Clin Gastroenterol Hepatol. 2009;7:874\u201381.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"59_CR58","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.cgh.2009.11.024","volume":"8","author":"MD Long","year":"2010","unstructured":"Long MD, Herfarth HH, Pipkin CA, et al. Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2010;8:268\u201374.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"59_CR59","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1053\/j.gastro.2011.06.050","volume":"141","author":"L Peyrin-Biroulet","year":"2011","unstructured":"Peyrin-Biroulet L, Khosrotehrani K, Carrat F, et al. Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease. Gastroenterology. 2011;141:1621\u20138.","journal-title":"Gastroenterology"},{"key":"59_CR60","first-page":"643","volume":"19","author":"KN Syrigos","year":"2005","unstructured":"Syrigos KN, Tzannou I, Katirtzoglou N, et al. Skin cancer in the elderly. In Vivo. 2005;19:643\u201352.","journal-title":"In Vivo"},{"key":"59_CR61","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1053\/j.gastro.2012.05.004","volume":"143","author":"MD Long","year":"2012","unstructured":"Long MD, Martin CF, Pipkin CA, et al. Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease. Gastroenterology. 2012;143:390\u20139.","journal-title":"Gastroenterology"},{"key":"59_CR62","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1136\/ard.2010.149419","volume":"70","author":"X Mariette","year":"2011","unstructured":"Mariette X, Matucci-Cerinic M, Pavelka K, et al. Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis. Ann Rheum Dis. 2011;70:1895\u2013904.","journal-title":"Ann Rheum Dis"},{"key":"59_CR63","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1038\/ajg.2012.181","volume":"107","author":"L Peyrin-Biroulet","year":"2012","unstructured":"Peyrin-Biroulet L, Chevaux JB, Bouvier AM, et al. Risk of melanoma in patients who receive thiopurines for inflammatory bowel disease is not increased. Am J Gastroenterol. 2012;107:1443\u20134.","journal-title":"Am J Gastroenterol"},{"key":"59_CR64","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/ibd.23021","volume":"19","author":"F Hoentjen","year":"2013","unstructured":"Hoentjen F, Seinen ML, Hanauer SB, et al. Safety and effectiveness of long-term allopurinol-thiopurine maintenance treatment in inflammatory bowel disease. Inflamm Bowel Dis. 2013;19:363\u20139.","journal-title":"Inflamm Bowel Dis"},{"key":"59_CR65","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/j.1572-0241.2007.01559.x","volume":"103","author":"PM Irving","year":"2008","unstructured":"Irving PM, Shanahan F, Rampton DS. Drug interactions in inflammatory bowel disease. Am J Gastroenterol. 2008;103:207\u201319.","journal-title":"Am J Gastroenterol"},{"key":"59_CR66","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.3899\/jrheum.090153","volume":"37","author":"J Bourre-Tessier","year":"2010","unstructured":"Bourre-Tessier J, Haraoui B. Methotrexate drug interactions in the treatment of rheumatoid arthritis: a systematic review. J Rheumatol. 2010;37:1416\u201321.","journal-title":"J Rheumatol"},{"key":"59_CR67","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2165\/00003088-200746030-00001","volume":"46","author":"A Teml","year":"2007","unstructured":"Teml A, Schaeffeler E, Herrlinger KR, et al. Thiopurine treatment in inflammatory bowel disease: clinical pharmacology and implication of pharmacogenetically guided dosing. Clin Pharmacokinet. 2007;46:187\u2013208.","journal-title":"Clin Pharmacokinet"},{"key":"59_CR68","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s11938-014-0024-9","volume":"12","author":"M Kim","year":"2014","unstructured":"Kim M, Dam A, Green J. Common GI drug interactions in the elderly. Curr Treat Options Gastroenterol. 2014;12:292\u2013309.","journal-title":"Curr Treat Options Gastroenterol"},{"key":"59_CR69","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1001\/archsurg.2011.194","volume":"146","author":"GG Kaplan","year":"2011","unstructured":"Kaplan GG, Hubbard J, Panaccione R, et al. Risk of comorbidities on postoperative outcomes in patients with inflammatory bowel disease. Arch Surg. 2011;146:959\u201364.","journal-title":"Arch Surg"},{"key":"59_CR70","doi-asserted-by":"publisher","first-page":"S190","DOI":"10.1016\/S1873-9946(14)60424-4","volume":"8","author":"W Fries","year":"2014","unstructured":"Fries W, Viola A, Mannetti N, et al. P303 ulcerative colitis (UC) in the elderly\u2013moderate at onset but then a milder course? An IG-IBD study. J Crohns Colitis. 2014;8:S190\u20131.","journal-title":"J Crohns Colitis"},{"key":"59_CR71","doi-asserted-by":"publisher","first-page":"S293","DOI":"10.1016\/S1873-9946(14)60662-0","volume":"8","author":"A Viola","year":"2014","unstructured":"Viola A, Cantoro L, Monterubbianesi R, et al. P542 Crohn\u2019s disease (CD) in the elderly \u2013 an IG-IBD study. J Crohns Colitis. 2014;8:S293\u20134.","journal-title":"J Crohns Colitis"},{"key":"59_CR72","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1001\/archsurg.136.12.1396","volume":"136","author":"G Almogy","year":"2001","unstructured":"Almogy G, Sachar DB, Bodian CA, et al. Surgery for ulcerative colitis in elderly persons: changes in indications for surgery and outcome over time. Arch Surg. 2001;136:1396\u2013400.","journal-title":"Arch Surg"},{"key":"59_CR73","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00595-013-0563-z","volume":"44","author":"H Ikeuchi","year":"2014","unstructured":"Ikeuchi H, Uchino M, Matsuoka H, et al. Prognosis following emergency surgery for ulcerative colitis in elderly patients. Surg Today. 2014;44:39\u201343.","journal-title":"Surg Today"},{"key":"59_CR74","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1001\/archsurg.140.6.534","volume":"140","author":"JR Chapman","year":"2005","unstructured":"Chapman JR, Larson DW, Wolff BG, et al. Ileal pouch-anal anastomosis: does age at the time of surgery affect outcome? Arch Surg. 2005;140:534\u20139.","journal-title":"Arch Surg"},{"key":"59_CR75","first-page":"221","volume":"238","author":"CP Delaney","year":"2003","unstructured":"Delaney CP, Fazio VW, Remzi FH, et al. Prospective, age-related analysis of surgical results, functional outcome, and quality of life after ileal pouch-anal anastomosis. Ann Surg. 2003;238:221\u20138.","journal-title":"Ann Surg"},{"key":"59_CR76","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.amjsurg.2003.07.001","volume":"186","author":"WE Longo","year":"2003","unstructured":"Longo WE, Virgo KS, Bahadursingh AN, et al. Patterns of disease and surgical treatment among United States veterans more than 50 years of age with ulcerative colitis. Am J Surg. 2003;186:514\u20138.","journal-title":"Am J Surg"},{"key":"59_CR77","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1097\/MIB.0b013e3182802b3e","volume":"19","author":"PL Lakatos","year":"2013","unstructured":"Lakatos PL, Vegh Z, Lovasz BD, et al. Is current smoking still an important environmental factor in inflammatory bowel diseases? Results from a population-based incident cohort. Inflamm Bowel Dis. 2013;19:1010\u20137.","journal-title":"Inflamm Bowel Dis"},{"key":"59_CR78","first-page":"85","volume":"114","author":"JK Triantafillidis","year":"2010","unstructured":"Triantafillidis JK, Mantzaris G, Karagiannis J, et al. Similar response to adalimumab in patients with active Crohn\u2019s disease either naive to biologic agents or with prior loss of response or intolerance to infliximab. Rev Med Chir Soc Med Nat Iasi. 2010;114:85\u201390.","journal-title":"Rev Med Chir Soc Med Nat Iasi"},{"key":"59_CR79","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s10620-006-3103-5","volume":"51","author":"AM Meyer","year":"2006","unstructured":"Meyer AM, Ramzan NN, Heigh RI, et al. Relapse of inflammatory bowel disease associated with use of nonsteroidal anti-inflammatory drugs. Dig Dis Sci. 2006;51:168\u201372.","journal-title":"Dig Dis Sci"},{"key":"59_CR80","doi-asserted-by":"crossref","unstructured":"Miao XP, Li JS, Ouyang Q, et al. Tolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel disease. Cochrane Database Syst Rev 2014;10:Cd007744.","DOI":"10.1002\/14651858.CD007744.pub2"},{"key":"59_CR81","doi-asserted-by":"crossref","unstructured":"Martin TD, Chan SS, Hart AR. Environmental factors in the relapse and recurrence of inflammatory bowel disease: a review of the literature. Dig Dis Sci 2014","DOI":"10.1007\/s10620-014-3437-3"},{"key":"59_CR82","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1136\/gut.2010.224154","volume":"60","author":"C Mowat","year":"2011","unstructured":"Mowat C, Cole A, Windsor A, et al. Guidelines for the management of inflammatory bowel disease in adults. Gut. 2011;60:571\u2013607.","journal-title":"Gut"},{"key":"59_CR83","first-page":"3","volume":"14","author":"E Kugelberg","year":"2014","unstructured":"Kugelberg E. T cell memory: the effect of ageing on CD8+ T cells. Nat Rev Immunol. 2014;14:3\u20133.","journal-title":"Nat Rev Immunol"},{"key":"59_CR84","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cger.2013.10.002","volume":"30","author":"HA Horton","year":"2014","unstructured":"Horton HA, Kim H, Melmed GY. Vaccinations in older adults with gastrointestinal diseases. Clin Geriatr Med. 2014;30:17\u201328.","journal-title":"Clin Geriatr Med"},{"key":"59_CR85","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/jgh.12712","volume":"30","author":"Y Cossio-Gil","year":"2015","unstructured":"Cossio-Gil Y, Martinez-Gomez X, Campins-Marti M, et al. Immunogenicity of hepatitis B vaccine in patients with inflammatory bowel disease and the benefits of revaccination. J Gastroenterol Hepatol. 2015;30:92\u20138.","journal-title":"J Gastroenterol Hepatol"},{"key":"59_CR86","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1002\/ibd.20943","volume":"15","author":"GY Melmed","year":"2009","unstructured":"Melmed GY. Vaccination strategies for patients with inflammatory bowel disease on immunomodulators and biologics. Inflamm Bowel Dis. 2009;15:1410\u20136.","journal-title":"Inflamm Bowel Dis"},{"key":"59_CR87","first-page":"53","volume":"4","author":"MC Mattar","year":"2011","unstructured":"Mattar MC, Lough D, Pishvaian MJ, et al. Current management of inflammatory bowel disease and colorectal cancer. Gastrointest Cancer Res. 2011;4:53\u201361.","journal-title":"Gastrointest Cancer Res"},{"key":"59_CR88","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1055\/s-0029-1215214","volume":"41","author":"A Crispin","year":"2009","unstructured":"Crispin A, Birkner B, Munte A, et al. Process quality and incidence of acute complications in a series of more than 230,000 outpatient colonoscopies. Endoscopy. 2009;41:1018\u201325.","journal-title":"Endoscopy"},{"key":"59_CR89","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1093\/jnci\/95.3.230","volume":"95","author":"NM Gatto","year":"2003","unstructured":"Gatto NM, Frucht H, Sundararajan V, et al. Risk of perforation after colonoscopy and sigmoidoscopy: a population-based study. J Natl Cancer Inst. 2003;95:230\u20136.","journal-title":"J Natl Cancer Inst"},{"key":"59_CR90","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.cgh.2009.10.007","volume":"8","author":"CW Ko","year":"2010","unstructured":"Ko CW, Riffle S, Michaels L, et al. Serious complications within 30 days of screening and surveillance colonoscopy are uncommon. Clin Gastroenterol Hepatol. 2010;8:166\u201373.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"59_CR91","doi-asserted-by":"publisher","first-page":"795","DOI":"10.7326\/0003-4819-133-10-200011210-00012","volume":"133","author":"CN Bernstein","year":"2000","unstructured":"Bernstein CN, Blanchard JF, Leslie W, et al. The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study. Ann Intern Med. 2000;133:795\u20139.","journal-title":"Ann Intern Med"},{"key":"59_CR92","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1002\/ibd.21601","volume":"17","author":"JP Etzel","year":"2011","unstructured":"Etzel JP, Larson MF, Anawalt BD, et al. Assessment and management of low bone density in inflammatory bowel disease and performance of professional society guidelines. Inflamm Bowel Dis. 2011;17:2122\u20139.","journal-title":"Inflamm Bowel Dis"},{"key":"59_CR93","doi-asserted-by":"crossref","unstructured":"Lau AN, Adachi JD. Bone aging. In: Geriatric rheumatology. Springer; 2011. p. 11\u201316.","DOI":"10.1007\/978-1-4419-5792-4_2"},{"key":"59_CR94","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1053\/gast.2003.50106","volume":"124","author":"CN Bernstein","year":"2003","unstructured":"Bernstein CN, Leslie WD, Leboff MS. AGA technical review on osteoporosis in gastrointestinal diseases. Gastroenterology. 2003;124:795\u2013841.","journal-title":"Gastroenterology"},{"key":"59_CR95","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1056\/NEJMra070553","volume":"357","author":"MF Holick","year":"2007","unstructured":"Holick MF. Vitamin D, deficiency. N Engl J Med. 2007;357:266\u201381.","journal-title":"N Engl J Med"}],"container-title":["Current Treatment Options in Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-015-0059-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11938-015-0059-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-015-0059-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-015-0059-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T21:15:27Z","timestamp":1649884527000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11938-015-0059-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,11]]},"references-count":95,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["59"],"URL":"https:\/\/doi.org\/10.1007\/s11938-015-0059-6","relation":{},"ISSN":["1092-8472","1534-309X"],"issn-type":[{"value":"1092-8472","type":"print"},{"value":"1534-309X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,11]]},"assertion":[{"value":"11 June 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}